Welcome to our dedicated page for AXS Cannabis ETF news (Ticker: THCX), a resource for investors and traders seeking the latest updates and insights on AXS Cannabis ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AXS Cannabis ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AXS Cannabis ETF's position in the market.
EDMONTON, Alberta, June 28, 2021 – Nova Cannabis Inc. (TSXV:NOVC, OTCQB:NVACF) announced a live presentation at VirtualInvestorConferences.com on June 30 at 4:30 PM ET. CEO Darren Karasiuk and CFO David Gordey will discuss the company's growth and initiatives. Investors can engage in real-time questions or access an archived webcast after the event. Notable highlights include an over 120% sales increase at converted stores and plans for 30 Value Buds stores in Ontario by year-end 2021.
High Tide Inc. has been added to the Cannabis ETF (NYSE: THCX), an indication of growing confidence in its business progress, particularly in the U.S. market. CEO Raj Grover highlighted this addition as a strategy to enhance visibility among U.S. investors. High Tide, Canada's most profitable recreational cannabis retailer, operates 85 locations across multiple provinces and aims to further expand its reach. The THCX ETF tracks a portfolio of 33 cannabis-related stocks, aiming to capitalize on the industry's growth.
